Skip to main content

ORIGINAL RESEARCH article

Front. Public Health, 13 October 2022
Sec. Environmental health and Exposome
This article is part of the Research Topic Urban Heat, Air Pollution, Greenness and Health View all 24 articles

Short-term exposure to ambient fine particulate matter and psoriasis: A time-series analysis in Beijing, China

\nJunhui Wu,Junhui Wu1,2Hongbo Chen,Hongbo Chen1,2Ruotong YangRuotong Yang2Huan YuHuan Yu2Shaomei Shang*&#x;Shaomei Shang1*Yonghua Hu,*&#x;Yonghua Hu2,3*
  • 1School of Nursing, Peking University, Beijing, China
  • 2Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China
  • 3Medical Informatics Center, Peking University, Beijing, China

Background: Ambient fine particulate matter (PM2.5) adversely affects human health and has been linked to a variety of skin disorders. However, little is known about the effects of PM2.5 on psoriasis.

Methods: The Beijing Medical Claim Data for Employees database recorded 500,266 outpatient visits for psoriasis during 2010–2017. A generalized additive quasi-Poisson model was used to examine the relationship between daily PM2.5 concentrations and outpatient visits for psoriasis with stratification by sex, age, and season.

Results: Short-term exposure to PM2.5 was associated with outpatient visits for psoriasis-related health concerns. A same-day increase of 10 μg/m3 in PM2.5 concentrations was associated with a 0.29% (95% confidence interval: 0.26–0.32%) increase in daily outpatient visits for psoriasis. Female and older patients appeared to be more sensitive to the effects of PM2.5 (P < 0.05).

Conclusions: Short-term elevations in PM2.5 concentrations may be associated with exacerbations in psoriasis. Further work is warranted to confirm the findings and elucidate the underlying biological mechanisms.

Background

Psoriasis is a common skin disorder and appears mainly in the form of chronic plaque psoriasis (psoriasis vulgaris) (1). Psoriasis is characterized by erythematous plaques covered by silvery lamellar scales, and common symptoms are pain, itching, and bleeding (2). Globally, psoriasis affects approximately 125 million individuals, and its prevalence is estimated at 3.2–8% (1, 3). The condition exerts significant physical, emotional, and social burdens on patients, including issues such as disfiguration, comorbidities (e.g., cardiovascular disease, psoriatic arthritis, and depression), and reduced ability to work (3, 4). There is no known cure for psoriasis (1), and the periodic recurrence and remission of symptoms consume substantial medical resources, especially in the outpatient department (1, 5). The underlying etiology of psoriasis is unclear, and may be a complex combination of immunological, environmental, and genetic factors that lead to clinically heterogeneous disease (6). Over the past few decades, an apparent upward trend in the prevalence of psoriasis has been observed in developed nations, coinciding with economic development and the accompanying environmental changes (710). Furthermore, several studies have reported that environmental factors such as airborne pollution increase the risk for skin disease (6). There is growing concern that air pollution may also have a detrimental effect on psoriasis.

Air pollution is an important and global risk factor for mortality, with an estimated 4.9 million deaths and 147 million years of healthy life lost annually (11). In recent years, multiple studies have reported significant associations between airborne pollution and skin disorders such as eczema, acne, and atopic dermatitis (1214). However, the relationship between airborne pollution and psoriasis is uncertain. Among air pollutants, particulate matter with an aerodynamic diameter < 2.5 μm (PM2.5) has been identified as the greatest threat to human health (1518), as the small particles can easily penetrate epithelial and endothelial cells, diffusing into blood and lymph circulation (19) and both inducing and exacerbating disease states (20, 21). Levels of PM2.5 pollution in China are among the highest worldwide and have been estimated to cause approximately 1 million premature deaths each year (22).

Some epidemiological studies have alluded to a possible link between PM2.5 and psoriasis, but not in detail. Previous studies conducted in Korea and Italy were conducted in low-level PM2.5 area, and their representation was limited (1, 2, 6, 23). In the present study, we hypothesized that short-term exposure to PM2.5 might contribute to the exacerbation of psoriasis. We used a time-series analysis to study the relationship between short-term exposure to PM2.5 and outpatient visits for psoriasis in Beijing, China.

Methods

Data collection

We collected daily PM2.5 concentrations from reports issued by the United States Embassy air monitoring station for the period between January 1, 2010 and December 31, 2017. These were the only consistent monitoring data we could access because China did not include PM2.5 in the air quality standard until 2013. Previous studies that compared PM2.5 levels recorded by this source and city-wide PM2.5 levels, found similar trends, and this data source has been used in multiple studies (24). The validity and reliability of the data have been demonstrated in detail in previous work (25) and are also described in Appendix S1. Daily mean temperature and relative humidity for the study period were obtained from the Chinese Meteorological Bureau. Personal identifiers and private information for the patients were removed for privacy; therefore, institutional review board approval and patient consent were not required.

Data on outpatient visits for psoriasis from January 1, 2010 to December 31, 2017 were obtained from the Beijing Medical Claim Data for Employees database, which covers all Beijing participants with basic medical insurance and includes all working or retired employees. The database records all medical claim data and basic demographics, date of visit, medications, and clinical diagnosis in Chinese and corresponding International Classification of Disease, 10th Revision codes. We used code L40.001 to identify cases of psoriasis. We only included patients with a primary diagnosis of psoriasis. Patients under 18 years were excluded. Beijing has a permanent population of ~21 million, of which more than 17.8 million (almost 85%) are included in the claim database. To control for potential residual confounding, we stratified the findings in subsequent analyses.

Statistical analysis

We used a generalized additive quasi-Poisson model to evaluate the relationship between PM2.5 concentrations and psoriasis-associated outpatient visits. This model has been widely used and refined for air pollution and health-related time-series studies (2629). Confounding covariates such as day of the week, public holiday, calendar time, temperature, and relative humidity were added to the main model (30, 31) and used as follows:

Log[E(Yt)]=α+βPM2.5+day of the week+ public holiday+s(calendar time, 7 per year)+ s(temperature,6)+s(relative humidity,3)

where E(Yt) refers to the expected number of psoriasis-associated outpatient visits on day t, α represents the model intercept, β denotes the log (relative risk) of morbidity relative to unit increase in PM2.5 levels, and s() represents a smoothing based on the penalized splines. Holidays mainly include every weekend and three official traditional festivals. Following the approaches in several relevant studies (32, 33), we selected the degrees of freedom for calendar time, temperature, and relative humidity. To confirm the robustness of our findings, sensitivity analyses were conducted using various degrees of freedom (34).

We applied a penalized cubic regression spline for PM2.5 concentration, a widely used approach that can better achieve the purpose of evaluating the temporal correlation between PM2.5 concentrations and daily outpatient visits for psoriasis (35). Consistent with previous studies, and considering the skin directly exposed to PM2.5, we assessed the relationship between PM2.5 levels and psoriasis-associated outpatient visits by constructing models with a single-day lag from the current day (lag 0) up to the previous 3 days (lag 1, lag 2, and lag 3), and with 2-day (lag 0–1), 3-day (lag 0–2), and 4-day (lag 0–3) moving average concentrations. To examine effects in subgroups, we stratified the analyses by age (<65 and ≥65 years), sex, and season. The warm season was defined as April to September and the cool season was defined as October to March (36). Z tests were used to assess statistical differences between subgroups (37). The degrees of freedom and parameters set in the main model is consistent with those in subgroup analysis.

All findings are presented as the percentage change and 95% confidence interval in daily psoriasis-associated outpatient visits for each 10-μg/m3 increase in ambient PM2.5. We used the “mgcv” and “nlme” packages in R 3.2.2 to analyze the data. Percentage change was calculated as (relative risk – 1) × 100. Statistical significance was defined as two-sided P < 0.05.

Results

Table 1 lists the characteristics of the psoriasis patients in our study. During the study period (January 1, 2010 to December 31, 2017), a total of 500,266 outpatient visits for psoriasis were identified in the health claims database. More than half (56.93%) of the patients were men; 15.96% of the patients were older than 65 years, and 56.03% of visits occurred in the cool season.

TABLE 1
www.frontiersin.org

Table 1. Characteristics of outpatient visits for psoriasis between January 1, 2010 and December 31, 2017 in Beijing, China.

Table 2 summarizes the descriptive statistics for the psoriasis-associated outpatient visits, PM2.5 concentrations, and weather conditions. The daily mean number of outpatient visits was 171 (standard deviation: 208). The annual average of PM2.5 concentrations was 86.8 μg/m3 (standard deviation: 74.3 μg/m3), with a maximum of 537.3 μg/m3. Figure 1 shows the association of PM2.5 concentrations with psoriasis-associated outpatient visits. There was a clear exposure-response association between the same-day (lag 0) daily average concentrations of PM2.5 and outpatient visits for psoriasis.

TABLE 2
www.frontiersin.org

Table 2. Distribution of daily outpatient visits for psoriasis, fine particulate matter (PM2.5) concentrations, and meteorological conditions.

FIGURE 1
www.frontiersin.org

Figure 1. Concentration-response curve (solid line) for daily average concentrations of airborne fine particulate matter with three degrees of freedom and the log-transformed relative risk of outpatient visits for psoriasis between January 1, 2010 and December 31, 2017 in Beijing, China. The relative risk is adjusted for temperature, relative humidity, public holiday, and day of the week. Dotted lines represent the 95% confidence intervals.

Table 3 presents the estimated relationships between acute elevations in PM2.5 concentrations and increases in outpatient visits for psoriasis. A 10-μg/m3 increase in PM2.5 levels corresponded to an increase of 0.29% (95% confidence interval: 0.26–0.32%) in same-day (lag 0) outpatient visits for psoriasis.

TABLE 3
www.frontiersin.org

Table 3. Increases in outpatient visits for psoriasis associated with a 10-μg/m3 increase in levels of airborne fine particulate matter for various lags.

Table 4 lists the subgroup estimates. The association between PM2.5 concentrations and psoriasis-associated outpatient visits was greater in women (0.35%, 95% confidence interval: 0.30–0.39%) and in older patients (0.41%, 95% confidence interval: 0.34–0.48%). Sensitivity analyses confirmed these results (Table 5). The changes in degrees of freedom for calendar time (6–9), temperature (5–8), and relative humidity (3–6) did not substantially change the findings, indicating that the association was robust.

TABLE 4
www.frontiersin.org

Table 4. Increases in outpatient visits for psoriasis associated with a 10-μg/m3 increase in airborne fine particulate matter stratified by sex, age group, and season.

TABLE 5
www.frontiersin.org

Table 5. Percentage change in same-day (lag 0) outpatient visits for psoriasis associated with a 10-μg/m3 increase in airborne concentrations of fine particulate matter using various degrees of freedom (df) for calendar time, temperature, and relative humidity.

Discussion

In this citywide time-series analysis, we found significant and positive associations between PM2.5 levels and outpatient visits for psoriasis. This introduces fine particulate matter as a factor in psoriasis exacerbation. To our knowledge, this is the first large-scale citywide research in China to comprehensively assess the acute effect of PM2.5 on psoriasis-associated outpatient visits. Although previous correlation studies have explored the association in some low-level PM2.5 areas, the results of our study are meaningful for the developing countries with more serious air pollution problem. Our findings provide new evidence that may assist in improving targeted intervention strategies for psoriasis.

In developed and Western nations, regular outpatient visits often require an appointment and treatments may not be available on the same day or at local clinics. Furthermore, as previous studies have indicated, some psoriasis patients present with mild symptoms (1) and do not require immediate medical attention or hospitalization, therefore electing deferred outpatient services. Currently, China lacks a general practitioner-based referral system (38). Regular patient visits to the outpatient departments of hospitals do not require an appointment and are made on a first-come, first-served basis (39). In 2014, 95% of hospital visits in China were outpatient visits (39, 40). This is the main manner by which Chinese patients obtain medical advice, and the daily count of outpatient visits is a good indicator by which to evaluate the association of air pollution and psoriasis. We included a citywide outpatient visit dataset to ensure the representativeness and authenticity of our findings.

We found that increases in PM2.5 concentrations correlated with outpatient visits for psoriasis. A 10-μg/m3 increase in PM2.5 levels corresponded to a 0.29% increase in same-day outpatient visits. Although the risk is relatively weak, the public health burden is extensive in China because of its large population and considerable air pollution.

To date, only two studies have investigated the effect of PM2.5 on psoriasis. A citywide survey in Korea found that every 10 μg/m3 increase in PM2.5 resulted in patient visit increases of 2.71% (95% CI 0.76–4.71; P < 0.01) (41). Another observational study with both case-crossover and cross-sectional design conducted in Italy also suggested that exposure to mean PM2.5 over 15 μg/m3 in the 60 days before assessment were associated with a higher risk of psoriasis area and severity index 5 or greater point worsening (adjusted odds ratio, 1.25; 95% CI, 1.0–1.57) (42). Despite some differences in study design and method, the evidence from these two studies strongly supports our study. Multivariate negative binomial regression analysis was conduct in the study of Korea rather than Poisson model because there were over dispersion of data. In addition, the health effects are greater at low-level air pollution area generally. These may account for the larger effect size in Korea. There are a lot of differences between the Italian study and our approach. For the study location, the Italian study was based on hospital data, which could provide a more detailed observation of psoriasis pathological indicators and incorporate more accurate disease outcomes. In addition, based on cohort data, this study could record patients' repeated hospital admissions in detail, which also enabled both case-crossover and cross-sectional design to be carried out. Although there are some differences in method, this study is consistent with our conclusions regarding the association between PM2.5 and psoriasis. Further studies with larger cohorts and different settings are needed to corroborate our findings.

Some modifiers of the relationship between PM2.5 pollution and psoriasis-associated outpatient visits were considered. In our study, the adverse effects of PM2.5 were more pronounced in older patients. Similar findings have been reported for other skin diseases (43, 44) and may reflect age-related differences in inflammatory or immune responses. In addition, older individuals are more vulnerable to high levels of airborne particulate pollution (45). Furthermore, a decline in skin barrier functions associated with aging may lead to increased skin sensitivity to environmental irritants, pathogens, and allergens (46). In the present study, we observed higher estimates in female patients. Duvetorp et al. reported that women with psoriasis were more likely to experience anxiety and depression because of the symptoms, resulting in more frequent hospital visits when the disease worsened (47). From our findings, we recommend that older and female patients with psoriasis reduce their personal skin exposure during periods of severe PM2.5 pollution, even though we did not find significant differences in the effect of PM2.5 concentrations on psoriasis between seasons. The relationship between season and health effects should be investigated further.

Although our findings suggest that PM2.5 pollution is related to psoriasis exacerbations, little is known about the underlying biological mechanisms. Research indicates that multiple mechanisms may mediate the adverse effects of air pollution on skin by influencing skin microflora, activating aromatic hydrocarbon receptors, and inducing inflammatory responses and oxidative stress (48). These mechanisms may be similar in the pathogenesis of psoriasis (6). For example, there is evidence that the adverse effects of polycyclic aromatic hydrocarbons in PM2.5 are mediated by activation of the aryl hydrocarbon receptor and may lead to autoimmune conditions (48). Transcriptomic analysis has shown that airborne PM2.5 may affect the expression of psoriasis-related genes and pro-inflammatory cytokines and exerts adverse effects on human keratinocytes (49). Moreover, a study in human embryonic stem cells reported that PM2.5 can disrupt keratinocyte differentiation and the expression of genes related to inflammation and psoriasis (21). Overall, the mechanism by which PM2.5 affects psoriasis requires detailed study.

Our study has some limitations. First, it is an ecological study and individual exposure was not determined. Second, because the information was limited, we did not investigate other potential modifiers, such as comorbidities and nutrition, which may be associated with psoriasis. And different stratification by age may also cause bias, and more studies are needed to further explore the association in different age subgroups. Third, the PM2.5 monitoring data were provided only by one source, and the lack of authoritative records of other air pollutants limits our investigation of the independent effects of PM2.5, requiring verification of the findings. Fourth, because the lack of recent statistical data related to the incidence of psoriasis in Beijing city, and in our study a same person may have multiple visits, it is difficult to calculate the population attributable fraction accurately, more studies are needed to further explore these issues.

Conclusion

The present study provides robust evidence that short-term elevations in PM2.5 levels are related to the risk of psoriasis. Long-term observations, estimates of personal exposure, and consideration of other pollutants and lifestyle factors are required.

Data availability statement

The data analyzed in this study was obtained from private datasets. Requests to access these datasets should be directed to yhhu@bjmu.edu.cn.

Author contributions

JW contributed to the study concept, had full access to all the data in the study, take responsibility for the integrity of the work as a whole, and from inception to published article. RY, HY, JW, and HC contributed to the statistical analysis and tables' development of this article. SS and YH interpreted the findings and drafted the article. All authors contributed to the critical revision of the article for important intellectual content.

Funding

This work was supported by the National Natural Science Foundation of China (Nos. 81872695 and 81972158), National Key Research and Development Program of China (Nos. 2020YFC2008800 and 2020YFC2008801), and China Postdoctoral Science Foundation (No. 2022TQ0017). The funders were not involved in the research and preparation of the article, including study design; collection, analysis, and interpretation of data; writing of the article; no in the decision to submit it for publication.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fpubh.2022.1015197/full#supplementary-material

Abbreviations

CI, confidence interval; PM2.5, particulate matter with an aerodynamic diameter < 2.5 μm.

References

1. Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis. A review. JAMA. (2020) 323:1945–60. doi: 10.1001/jama.2020.4006

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Boehncke WH, Schön M. Psoriasis. Lancet. (2015) 386:983–94. doi: 10.1016/S0140-6736(14)61909-7

PubMed Abstract | CrossRef Full Text | Google Scholar

3. World Health Organization. Global Report on Psoriasis. World Health Organization (2016).

Google Scholar

4. Sampogna F, Tabolli SD. A IDI: multipurpose psoriasis research on vital experiences (IMPROVE) investigators. Living with psoriasis: prevalence of shame, anger, worry, and problems in daily activities and social life. Acta Derm Venereol. (2012) 92:299–303. doi: 10.2340/00015555-1273

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Yang Q, Qu L, Tian H, Hu Y, Peng J, Yu X, et al. Prevalence and characteristics of psoriatic arthritis in Chinese patients with psoriasis %J Journal of the European Academy of Dermatology and Venereology. J Eur Acad Dermatol Venereol. (2011) 25:1409–14. doi: 10.1111/j.1468-3083.2011.03985.x

PubMed Abstract | CrossRef Full Text | Google Scholar

6. GrŽelj JM, Sollner Dolenc M. The role of xenobiotics in triggering psoriasis. Arch Toxicol. (2020) 94:3959–82. doi: 10.1007/s00204-020-02870-8

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Shao CG, Zhang GW, Wang GC. Distribution of psoriasis in China: a nationwide screening. Proc Chin Acad Med Sci. (1987) 2:59–65.

PubMed Abstract | Google Scholar

8. Ding X, Wang T, Shen Y, Wang X, Zhang J. Prevalence of psoriasis in China: a population-based study in six cities. Eur J Dermatol. (2012) 22:663–7. doi: 10.1684/ejd.2012.1802

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol. (2009) 60:218–24. doi: 10.1016/j.jaad.2008.09.022

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Danielsen K, Olsen AO, Wilsgaard T, Furberg AS. Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort. Br J Dermatol. (2013) 168:1303–10. doi: 10.1111/bjd.12230

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Health Effects Institute: State of Global Air 2019. Special Report. Boston, MA: Health Effects Institute (2019).

Google Scholar

12. Guo Q, Liang F, Tian L, Schikowski T, Liu W, Pan X. Ambient air pollution and the hospital outpatient visits for eczema and dermatitis in Beijing: a time-stratified case-crossover analysis. Environ Sci Processes Impacts. (2019) 21:163–73. doi: 10.1039/C8EM00494C

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Park S, Ha KH, Kim TG, Kim HC, Kim C, Oh SH. Air pollution and risk of hospital outpatient visits for eczematous skin disorders in metropolitan cities of South Korea. Br J Dermatol. (2021) 2021:79. doi: 10.1111/bjd.20079

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Roberts WE. Air pollution and skin disorders. Int J Women Dermatol. (2020) 7:91–7. doi: 10.1016/j.ijwd.2020.11.001

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Pope CA III, Dockery DW. Health effects of fine particulate air pollution: lines that connect. J Air Waste Manag Assoc 1995. (2006) 56:709–42. doi: 10.1080/10473289.2006.10464485

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Lu F, Xu D, Cheng Y, Dong S, Guo C, Jiang X, et al. Systematic review and meta-analysis of the adverse health effects of ambient PM2.5 and PM10 pollution in the Chinese population. Environ Res. (2015) 136:196–204. doi: 10.1016/j.envres.2014.06.029

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Wilson WE, Suh HH. Fine particles and coarse particles: concentration relationships relevant to epidemiologic studies. J Air Waste Manag Assoc 1995. (1997) 47:1238–49. doi: 10.1080/10473289.1997.10464074

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Zhang H, Wang Z, Zhang W. Exploring spatiotemporal patterns of PM2.5 in China based on ground-level observations for 190 cities. Environ Poll (Barking Essex: 1987). (2016) 216:559–67. doi: 10.1016/j.envpol.2016.06.009

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Tian Y, Xiang X, Juan J, Sun K, Song J, Cao Y, Hu Y. Fine particulate air pollution and hospital visits for asthma in Beijing, China. Enviro Pollut (Barking, Essex: 1987). (2017) 230:227–33. doi: 10.1016/j.envpol.2017.06.029

PubMed Abstract | CrossRef Full Text | Google Scholar

20. GBD 2016 Lower Respiratory Infections Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis. (2017) 17:1133–61.

PubMed Abstract | Google Scholar

21. Cheng Z, Liang X, Liang S, Yin N, Faiola F. A human embryonic stem cell-based in vitro model revealed that ultrafine carbon particles may cause skin inflammation and psoriasis. J Environ Sci. (2020) 87:194–204. doi: 10.1016/j.jes.2019.06.016

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Xue T, Liu J, Zhang Q, Geng G, Zheng Y, Tong D. Rapid improvement of PM2.5 pollution and associated health benefits in China during 2013–2017. Sci China Earth Sci. (2019) v.62:7–16. doi: 10.1007/s11430-018-9348-2

CrossRef Full Text | Google Scholar

23. Xiao H, Zhang H. Skin inflammation and psoriasis may be linked to exposure of ultrafine carbon particles. J Environ Sci. (2020) 96:206–8. doi: 10.1016/j.jes.2020.06.028

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Wang JF, Hu MG, Xu CD, Christakos G, Zhao Y. Estimation of citywide air pollution in Beijing. PLoS ONE. (2013) 8:e53400. doi: 10.1371/journal.pone.0053400

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Wellenius GA, Burger MR, Coull BA, Schwartz J, Suh HH, Koutrakis P, et al. Ambient air pollution and the risk of acute ischemic stroke. Arch Intern Med. (2012) 172:229–34. doi: 10.1001/archinternmed.2011.732

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Li M, Wu Y, Tian YH, Cao YY, Song J, Huang Z, et al. Association between PM2.5 and daily hospital admissions for heart failure: a time-series analysis in Beijing. Int J Environ Res Public Health. (2018) 15:217. doi: 10.3390/ijerph15102217

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Ma YX, Yang SX, Yu Z, Jiao HR, Zhang YF, Ma BJ. A study on the short-term impact of fine particulate matter pollution on the incidence of cardiovascular diseases in Beijing, China. Atmos Environ. (2019) 215:7. doi: 10.1016/j.atmosenv.2019.116889

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Xu LJ, Shen SQ, Li L, Chen TT, Zhan ZY, Ou CQ. A tensor product quasi-Poisson model for estimating health effects of multiple ambient pollutants on mortality. Environ Health. (2019) 18:38. doi: 10.1186/s12940-019-0473-7

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Guo Y, Teixeira JP, Ryti N. Ambient particulate air pollution and daily mortality in 652 cities. N Engl J Med. (2019) 381:705–15. doi: 10.1056/NEJMc1913285

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Dominici F, Peng RD, Bell ML, Pham L, McDermott A, Zeger SL, et al. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. JAMA. (2006) 295:1127–34. doi: 10.1001/jama.295.10.1127

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Xiao D, Guo W, Xu D, Chen J, Liang Z, Zhang X. Three exposure metrics for fine particulate matter associated with outpatient visits for acute lower respiratory infection among children in Guangzhou, China. Front Public Health. (2022) 10:876496. doi: 10.3389/fpubh.2022.876496

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Liu C, Chen R, Sera F, Vicedo-Cabrera AM, Guo Y, Tong S, et al. Ambient particulate air pollution and daily mortality in 652 cities. N Engl J Med. (2019) 381:705–15. doi: 10.1056/NEJMoa1817364

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Tian Y, Liu H, Wu Y, Si Y, Song J, Cao Y, et al. Association between ambient fine particulate pollution and hospital admissions for cause specific cardiovascular disease: time series study in 184 major Chinese cities. BMJ (Clin Res Ed). (2019) 367:l6572. doi: 10.1136/bmj.l6572

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Chen R, Yin P, Meng X, Liu C, Wang L, Xu X, et al. Fine particulate air pollution and daily mortality. A nationwide analysis in 272 Chinese cities. Am J Respir Crit Care Med. (2017) 196:73–81. doi: 10.1164/rccm.201609-1862OC

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Tian Y, Xiang X, Juan J, Song J, Cao Y, Huang C, et al. Short-term effects of ambient fine particulate matter pollution on hospital visits for chronic obstructive pulmonary disease in Beijing, China. Environ Health. (2018) 17:21. doi: 10.1186/s12940-018-0369-y

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Wong CM, Ma S, Hedley AJ, Lam TH. Effect of air pollution on daily mortality in Hong Kong. Environ Health Perspect. (2001) 109:335–40. doi: 10.1289/ehp.01109335

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ (Clin Res Ed). (2003) 326:219. doi: 10.1136/bmj.326.7382.219

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Li Q, Xie P. Outpatient workload in China. Lancet. (2013) 381:1983–4. doi: 10.1016/S0140-6736(13)61198-8

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Xu X, Li B, Huang H. Air pollution and unscheduled hospital outpatient and emergency room visits. Environ Health Perspect. (1995) 103:286–9. doi: 10.1289/ehp.95103286

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Liu Y, Xie S, Yu Q, Huo X, Ming X, Wang J, et al. Short-term effects of ambient air pollution on pediatric outpatient visits for respiratory diseases in Yichang city, China. Environ Poll (Barking, Essex: 1987). (2017) 227:116–24. doi: 10.1016/j.envpol.2017.04.029

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Park TH PS, Cho MK, Kim S. Associations of particulate matter with atopic dermatitis and chronic inflammatory skin diseases in South Korea. Clin Exp Dermatol. (2022) 47:325–34. doi: 10.1111/ced.14910

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Bellinato F, Adami G, Vaienti S, Benini C, Gatti D, Idolazzi L, et al. Association between short-term exposure to environmental air pollution and psoriasis flare. JAMA Dermatol. (2022) 158:375–81. doi: 10.1001/jamadermatol.2021.6019

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Wang XW, Tian YH, Cao YY, Song J, Hu YH. Association between fine particulate air pollution and outpatient visits for eczema in Beijing, China: a time-series analysis. Biomed Environ Sci. (2019) 32:624–7. doi: 10.3967/bes2019.080

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Passeron T, Krutmann J, Andersen ML, Katta R. Clinical and biological impact of the exposome on the skin. J Eur Acad Dermatol Venereol. (2020) 34:4–25. doi: 10.1111/jdv.16614

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Weinberg A, Canniff J, Rouphael N, Mehta A, Mulligan M, Whitaker JA, et al. Varicella-Zoster virus-specific cellular immune responses to the live attenuated zoster vaccine in young and older adults. J Immunol Off J Am Assoc Immunol. (2017) 199:604–12. doi: 10.4049/jimmunol.1700290

PubMed Abstract | CrossRef Full Text | Google Scholar

46. Tanei R, Hasegawa Y. Atopic dermatitis in older adults: a viewpoint from geriatric dermatology. Geriatr Gerontol Int. (2016) 16:75–86. doi: 10.1111/ggi.12771

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Duvetorp A, Mrowietz U, Nilsson M, Seifert O. Sex and age influence the associated risk of depression in patients with psoriasis: a retrospective population study based on diagnosis and drug-use. Dermatology. (2020) 14:595–602. doi: 10.1159/000509732

PubMed Abstract | CrossRef Full Text | Google Scholar

48. Mancebo SE, Wang SQ. Recognizing the impact of ambient air pollution on skin health. J Eur Acad Dermatol Venereol. (2015) 29:2326–32. doi: 10.1111/jdv.13250

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Kim HJ, Bae IH, Son ED, Park J, Cha N, Na HW, et al. Transcriptome analysis of airborne PM2.5-induced detrimental effects on human keratinocytes. Toxicol Lett. (2017) 273:26–35. doi: 10.1016/j.toxlet.2017.03.010

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: fine particulate matter, outpatient visits, air pollution, psoriasis, time-series study

Citation: Wu J, Chen H, Yang R, Yu H, Shang S and Hu Y (2022) Short-term exposure to ambient fine particulate matter and psoriasis: A time-series analysis in Beijing, China. Front. Public Health 10:1015197. doi: 10.3389/fpubh.2022.1015197

Received: 09 August 2022; Accepted: 12 September 2022;
Published: 13 October 2022.

Edited by:

Yunquan Zhang, Wuhan University of Science and Technology, China

Reviewed by:

Xiang Li, The Chinese University of Hong Kong, China
Yuxiong Chen, Peking Union Medical College Hospital (CAMS), China

Copyright © 2022 Wu, Chen, Yang, Yu, Shang and Hu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Shaomei Shang, shangshaomei@126.com; Yonghua Hu, yhhu@bjmu.edu.cn

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.